Selskabets formål er at drive handel, engros og fabrikationsvirksomhed samt servicevirksomhed, navnlig inden for sundheds-, medicinal- og mejerisektoren.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 244.4 mio. | -19 mio. | 282 mio. | 209 mio. | 36 | |
CVR: 73128110
Secondary names: MILUPA A/S
Previous names: NUTRICIA NORDICA DANMARK A/S, NUTRICIA DANMARK A/S, NUTRICIA A/S
Compared to 327 companies in Engroshandel med andre fødevarer
Comparison is based on industry median values
Companies in the same industry and area
CVR 31871255
CVR 43652532
CVR 45841154
CVR 45837211
CVR 46457420
Manu Claessens joined the board
Manu Claessens left the board
Manu Claessens joined the board
Samuel Wolfenden joined the board
Maxime Komardine left the board
Ignasi Argente Arbos left the board
Danone A/S is currently facing financial challenges, as evidenced by a significant decline in profitability, reporting a loss of 19,011,326 DKK in 2024, following a loss of 62,480,418 DKK in 2023. Despite a revenue increase from 148,793,361 DKK in 2022 to 244,400,368 DKK in 2024, the company has struggled to maintain positive profit margins, with equity decreasing from 227,967,578 DKK in 2023 to 208,956,252 DKK in 2024. The substantial growth in revenue suggests a potential for recovery; however, the declining equity and ongoing losses raise concerns about its financial stability and operational efficiency within the food wholesale industry. Overall, while Danone A/S has expanded its revenue base, it must address its profitability issues to improve its financial health.
AI-generated summary